Document ID: chunk:federal_register_of_legislation:F2022N00216:clause:3_4
Version: federal_register_of_legislation:F2022N00216
Segment Type: clause
Provision Reference: sch 3 cl 4
Character Range: 1903–2810

4  Definitions
Note: A number of expressions used in this instrument are defined in subsection 3(1) of the Act, including the following:
(a) Australia-UK Mutual Recognition Agreement;
(b) member of EFTA;
(c) member of the European Community;
(d) non-EC/EFTA MRA.
  In this instrument:
Act means the Therapeutic Goods Act.
Australia-Canada Mutual Recognition Agreement means the Mutual Recognition Agreement on Conformity Assessment in Relation to Medicines Good Manufacturing Practice Inspection and Certification between the Government of Australia and the Government of Canada, as in force or existing at the commencement of this instrument.
Australia-Singapore Mutual Recognition Agreement means the Mutual Recognition Agreement on Conformity Assessment between the Government of Australia and the Government of the Republic of Singapore, as in force or existing at the commencement of this instrument.